{"id":"W1979174109","doi":"10.1056/nejmoa0807650","title":"Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1023,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"European Commission; Valeant Pharmaceuticals International; Gilead Sciences; Vertex Pharmaceuticals; Merz Pharmaceuticals; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Telaprevir; Ribavirin; Medicine; Virology; Boceprevir; Hepatitis C virus; Chronic hepatitis; Genotype; Pegylated interferon; Hepacivirus; Peginterferon alfa-2a; Protease inhibitor (pharmacology); Internal medicine; Gastroenterology; Virus; Viral load; Biology; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}